Breast cancer is currently classified into five intrinsic subtypes, typically using immunohistological markers (estrogen receptor [ER], progesterone receptor [PR], HER2 gene, and/or ERBB2 protein status), tumor grade, and/or proliferation. This evidence concerns the gene ERBB2 and breast carcinoma.